dc.contributor.author | Kaliamurthi, Satyavani | |
dc.contributor.author | Selvaraj, Gurudeeban | |
dc.contributor.author | Cakmak, Turgay | |
dc.contributor.author | Cakmak, Zeynep Elibol | |
dc.date.accessioned | 2021-03-02T22:07:43Z | |
dc.date.available | 2021-03-02T22:07:43Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Selvaraj G., Kaliamurthi S., Cakmak Z. E. , Cakmak T., "In silico validation of microalgal metabolites against Diabetes mellitus", DIABETES MELLITUS, cilt.20, sa.4, ss.301-307, 2017 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_0aecf8cb-9fca-4258-a15e-5d6ab4664c3a | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/13051 | |
dc.identifier.uri | https://doi.org/10.14341/dm8212 | |
dc.description.abstract | Aim. Present study aimed to evaluate the efficiency of microalgal metabolites as ligands for anti-diabetic target proteins viz., glucokinase, fructose-1, 6-bisphosphatase, glycogen synthase kinase, cytochrome P450, multi drug resistant protein, and peroxisome proliferator-activated receptor-gamma (PPAR gamma) via computational approach. | |
dc.language.iso | eng | |
dc.subject | Endokrinoloji ve Metabolizma Hastalıkları | |
dc.subject | Sağlık Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ENDOKRİNOLOJİ VE METABOLİZMA | |
dc.title | In silico validation of microalgal metabolites against Diabetes mellitus | |
dc.type | Makale | |
dc.relation.journal | DIABETES MELLITUS | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 20 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 301 | |
dc.identifier.endpage | 307 | |
dc.contributor.firstauthorID | 238296 | |